BBusiness Read More Novo’s CagriSema shows 25% weight loss in womenOctober 20, 2026 Novo on Tuesday said its next-generation obesity drug, CagriSema, showed 25% weight loss on average among adult women…
BBusiness Read More Novo’s Wegovy pill improves weight loss after switch from injectionsSeptember 30, 2026 People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…
MMarkets Read More 5 things to know before the stock market opens FridaySeptember 25, 2026 This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Friday. Your morning cup…
HHealth care Read More Novo Nordisk rebrands to ‘Novo’ under CEO Mike DoustdarSeptember 14, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
HHealth Read More Novo Nordisk stock rises after Wegovy recommended by UK’s drug price watchdogApril 1, 2026 Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4%…
BBusiness Read More Novo Nordisk stock falls as weight loss drug fails to beat Eli LillyFebruary 23, 2026 Novo Nordisk stock fell 15% Monday after it said its next-generation weight loss drug didn’t meet its key…